bioRxiv Science⌕ Search

Biology subjects

Sudol, A. S. L.

Publications and source records attributed to Sudol, A. S. L..

3 recordsLinked to original sources

Regulation of N-glycosylation efficiency by eukaryotic oligosaccharyltransferase

Oligosaccharyltransferase (OST) catalyses the key step of N-glycosylation, transferring immature N-glycans to select Asn residues in nascent proteins in the endoplasmic reticulum (ER). Asn are more likely to be glycosylated in the context of a "glycosylation sequon", N-x-S/T (x=P), but not every sequon is glycosylated. Tight positive and negative regulation of site-specific N-glycosylation across the glycoproteome is essential because some Asn require glycosylation for productive protein folding or function, while others must remain unglycosylated. Despite its importance, the underlying bases for this regulation are illdefined. Here we characterise the molecular determinants regulating OST catalytic efficiency. We identify preferred substrates of OST, and show that the local sequence determines glycosylation efficiency by fine-tuning binding to an extended groove in OST along an eight residue stretch centered at the Asn acceptor. Tight control of OST activity is achieved through a switch, set ON when a peptide binds with high complementarity to the groove, triggering release of the assisting base Glu350 for catalysis. Based on analysis of buried sequons, we identify sequence characteristics associated with inherently non-preferred acceptor substrates for OST, and show these have a high propensity for local secondary structure incompatible with the optimal conformation of a peptide bound to OST. Finally, we validate these mechanisms by examining the determinants of efficient glycosylation at a variably glycosylated Asn in a set of human Fabs. These mechanistic and functional insights show how local protein sequence controls glycosylation occupancy with immediate implications in secretory protein function and evolution, pathogen immunity and epistasis, and in engineering protein sequences for the desired degree of site-specific glycosylation.

biochemistry↗

Bespoke conformation and antibody recognition distinguishes the streptococcal immune evasion factors EndoS and EndoS2

The IgG-specific endoglycosidases EndoS and EndoS2 from Streptococcus pyogenes ablate IgG function by removing the conserved N-linked glycans present on the Fc region. Their role in immune evasion, by inactivation of IgG antibodies, has led these enzymes to be investigated as therapeutics for suppressing unwanted immune activation. Their activity and precise substrate specificity has also prompted the development of these enzymes as tools for engineering IgG glycosylation. Recent structural studies have revealed how EndoS drives specificity for IgG by binding the Fc peptide surface with a domain that has homology for a carbohydrate-binding module (CBM). Here, we present the crystal structure of the EndoS2-IgG1 Fc complex at 3.0 [A] resolution. Comparison with the EndoS-IgG1 Fc structure reveals a similar mode of interaction, but slightly different orientations resulting from different interfaces with glycosidase and CBM domains, leading to recognition of distinct Fc surfaces. These findings rationalise previous observations that non-catalytic domains cannot readily be substituted. The structural information presented here will guide the continued development of IgG-specific endoglycosidases in antibody glycoengineering and immunotherapy.

immunology↗

Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS

Enzymatic cleavage of IgG antibodies is a common strategy used by pathogenic bacteria to ablate immune effector function. The Streptococcus pyogenes bacterium secretes the protease IdeS and the glycosidase EndoS, which specifically catalyse cleavage and deglycosylation of human IgG, respectively. IdeS has received clinical approval for kidney transplantation in hypersensitised individuals, while EndoS has found application in engineering antibody glycosylation. Here, we present crystal structures of both enzymes in complex with their IgG1 Fc substrate, which was achieved using Fc engineering to disfavour preferential Fc crystallisation. The IdeS protease displays extensive Fc recognition and encases the antibody hinge. Conversely, the glycan hydrolase domain in EndoS traps the Fc glycan in a flipped-out conformation, while additional recognition of the Fc peptide is driven by the so-called carbohydrate binding module. Understanding the molecular basis of antibody recognition by bacterial enzymes will facilitate the development of next-generation enzymes for clinical and biotechnological use.

immunology↗